143 results
Page 4 of 8
8-K
EX-1.1
ulv99 niv2cksar
21 Feb 20
Agile Therapeutics Announces Proposed Underwritten Public Offering of Common Stock
4:46pm
424B5
ft47tzppedu4tjmiwn
21 Feb 20
Prospectus supplement for primary offering
4:26pm
424B5
acg dontye
20 Feb 20
Prospectus supplement for primary offering
5:28pm
8-K
EX-99.1
n1z7tx59xq8v566daf2
18 Feb 20
Regulation FD Disclosure
8:50am
8-K
EX-10.1
o4skiz6x8bvvdn95l2j4
12 Feb 20
Entry into a Material Definitive Agreement
8:00am
8-K
EX-99.1
oveycowip iagb
8 Jan 20
Results of Operations and Financial Condition
4:31pm
8-K
EX-1.1
sr1 gkddub
8 Nov 19
Entry into a Material Definitive Agreement
4:38pm
424B5
p2k70eak
8 Nov 19
Prospectus supplement for primary offering
4:34pm
8-K
EX-99.1
h46yv9sg3us8v4kp
28 Oct 19
Agile Therapeutics Reports Third Quarter 2019 Financial Results
8:10am
8-K
EX-1.1
10p5 hliilyjg1
2 Aug 19
Agile Therapeutics Announces Proposed Underwritten Public Offering of Common Stock
4:50pm
424B5
5ecoo
2 Aug 19
Prospectus supplement for primary offering
4:40pm
424B5
ibmpfrwf6jab1q04
1 Aug 19
Prospectus supplement for primary offering
4:21pm
8-K
EX-99.1
myd15f4rix347qm h1dx
1 Aug 19
Agile Therapeutics Reports Second Quarter 2019 Financial Results
8:14am
8-K
EX-99.1
j0wl lgwc34co2cmmq
28 Jun 19
Other Events
8:00am
8-K
0xd931xs6o3eru7ko
28 Jun 19
Other Events
8:00am
8-K
o5bnkw 7dx6iqk8
6 May 19
Other Events
4:29pm